Recent evidence suggested that LMP1 silencing slows cell growth and enhances chemosensitivity through inhibition of the AKT signalling pathway and its downstream factor phospho-FOXO1 in EBV-positive NPC cell line19. Here, AKT1 is linked to nasopharyngeal carcinoma.